Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
12/08/1994 | WO1994027583A2 Apoptosis inhibitors for treating neurodegenerative diseases |
12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
12/08/1994 | CA2163966A1 Alkaline and acid phosphatase inhibitors in treatment of neurological disorders |
12/08/1994 | CA2163887A1 Use of lignan derivatives for the preparation of pharmaceutical compositions for the treatment of states of amyloidosis |
12/08/1994 | CA2163867A1 1,2,3,4-tetrahydroquinoline-2,3,4-trione-3 or 4-oximes and use |
12/08/1994 | CA2163350A1 Opioid receptors: compositions and methods |
12/08/1994 | CA2161979A1 Cloning, expression and uses of dorsalin-1 |
12/08/1994 | CA2157186A1 Antidepressant dosage form |
12/08/1994 | CA2140532A1 Tricyclic cefem sulphones as elastase inhibitors |
12/08/1994 | CA2125077A1 Imidazopyridine |
12/07/1994 | EP0627432A1 6-Piperazinyl-1H-pyrazolo [3,4-b]pyridine-3-carboxylic Acids, Esters, Amides andrelated compounds, a process for their preparation and their use as medicaments |
12/07/1994 | EP0627407A1 (7S)-7-(2(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydro-naphthalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
12/07/1994 | EP0627400A1 Aromatic acetylcholinesterase inhibitors |
12/07/1994 | EP0626966A1 3-substituted imidazo(1,5-a)quinoxalines and quinazolines with cns activity |
12/07/1994 | EP0626961A1 Nitrosation process |
12/07/1994 | EP0626954A1 Benzocycloheptenes, benzoxepines and benzothiepines |
12/07/1994 | EP0626951A1 Benzisoxazole derivatives and pharmaceutical compositions containing them |
12/07/1994 | EP0626949A1 Antipsychotic nitrogen-containing bicyclic compounds |
12/07/1994 | EP0626947A1 Hydroisoindolines and hydroisoquinolines as psychotropic drugs |
12/07/1994 | EP0626853A1 Use of substituted adenine derivatives for treating multiple sclerosis |
12/07/1994 | EP0626851A1 Use of 3,5-diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine for the treatment of pain and dema |
12/07/1994 | EP0626848A1 The use of 4-aminopyridine in the treatment of a neurological condition |
12/07/1994 | EP0571511B1 Novel ureas and thioureas, preparation thereof and application in therapy |
12/07/1994 | EP0511222B1 Disubstituted piperidines and pyrrolidines as anticholinergic agents |
12/07/1994 | EP0505376B1 Muscarinic receptor antagonists |
12/07/1994 | CN1096029A Derivative of 2-(thien-2-yl) imidazo|2,1-6¨-benzothiazole-3-acetic acid, preparation and pharmaceutical application of same |
12/06/1994 | US5371237 Process for the production of 4-hydroxy-2-oxopyrrolidin-1-yl-acetamide |
12/06/1994 | US5371103 Thiochroman compounds |
12/06/1994 | US5371094 Azaheterocyclylmethyl-chromans for treating axiety |
12/06/1994 | US5371092 Use of paroxetine for the treatment of senile dementia, bulimia, migraine or anorexia |
12/06/1994 | US5371088 1-aryl-4-piperazinylcyclohexanecarbonitriles, the preparation and use thereof |
12/06/1994 | US5371087 Antipsychotic, analgesics, anticonvulsant and anxiolytic agent |
12/06/1994 | US5371082 Treatment of anxiety disorders |
12/06/1994 | US5370879 Formulations and their use in the treatment of neurological diseases |
12/06/1994 | CA2005072C Antispasmodic agent comprising creosote or its phenol derivative |
12/06/1994 | CA1333394C Apovincaminic acid derivatives |
11/30/1994 | EP0626367A1 (7S)-7-(1R)-2-(3-chlorophenyl)-2-hydroethylamino-5,6,7,8-tetrahydronaphtalen-2-yloxy acetic acid, their pharmaceutically acceptable salts with a beta-3-adrenergic agonist activity and pharmaceutical compositions containing them |
11/30/1994 | EP0625988A1 Allosteric modulators of the nmda receptor |
11/30/1994 | EP0625987A1 Aminoacetylmercaptoacetylamide derivatives useful as inhibitors of enkephalinase and ace |
11/30/1994 | EP0625982A1 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents |
11/30/1994 | EP0625981A1 Azabicyclo compounds as calcium channel antagonists |
11/30/1994 | EP0625979A1 Azabricyclic compounds as calcium channel antagonists |
11/30/1994 | EP0625978A1 Piperazine and piperidine derivatives, and their use as antipsychotics |
11/30/1994 | EP0625977A1 Piperazine derivatives as 5-ht1a antagonists |
11/30/1994 | EP0625969A1 Arylalkoxyphenoxy-imidazoline compounds |
11/30/1994 | EP0625903A1 Topical antiglaucoma compositions comprising carbonic anhydrase inhibitors and beta-blockers |
11/30/1994 | EP0531410B1 (+)-alpha-(2,3-dimethoxyphenyl)-1-[2-(fluorophenyl)ethyl]-4-piperidinemethanol |
11/30/1994 | CN1095720A Derivatives of benzoylecgonine, ecgonine and ecgonidine and methods for preparing and using same |
11/30/1994 | CN1095719A Neuroprotective 3,4-dihydro-2(1H)-quinolone compounds |
11/30/1994 | CN1095712A Compounds |
11/30/1994 | CN1095619A Health-care tortoise and soft-shelled turtle capsule and its prepn. method |
11/30/1994 | CN1026785C Process for the preparation of clausenamide and neoclausenamide, and of their derivatives |
11/29/1994 | US5369103 Piperazine derivatives |
11/29/1994 | US5368860 Preparation for transdermal drug administration |
11/24/1994 | WO1994026914A1 Adenoviral vectors of animal origin and use thereof in gene therapy |
11/24/1994 | WO1994026892A1 Bmp-11 compositions |
11/24/1994 | WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
11/24/1994 | WO1994026747A1 Ampa antagonists and a method of treatment therewith |
11/24/1994 | WO1994026746A1 [1,2,4]TRIAZOLO[4,3-a]QUINOXALINE COMPOUNDS, THEIR PREPARATION AND USE |
11/24/1994 | WO1994026740A1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists |
11/24/1994 | WO1994026736A1 Thioindole pyperidinyl derivatives used as antalgics |
11/24/1994 | WO1994026735A1 Substituted pyrrolidin-3-yl-alkyl-piperidines useful as tachykinin antagonists |
11/24/1994 | WO1994026733A1 Pyrimidine derivatives |
11/24/1994 | WO1994026712A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity |
11/24/1994 | WO1994026704A1 1-arylcycloalkyl sulphides, sulphoxides and sulphones for the treatment of depression, anxiety and parkinson's disease |
11/24/1994 | WO1994026693A1 Bicyclic amide derivatives and their use as muscle relaxants |
11/24/1994 | WO1994026692A1 Bicyclic amide derivatives and their use as muscle relaxants |
11/24/1994 | WO1994026301A1 New peptide antagonists at glutamate and nmda receptors |
11/24/1994 | WO1994026298A1 Methods for treating muscle diseases and disorders |
11/24/1994 | WO1994026277A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
11/24/1994 | WO1994026274A1 Treatment process with biologically active tropane derivatives |
11/24/1994 | WO1994026270A1 Transdermal therapeutic systems for the administration of serotonin agonists |
11/24/1994 | WO1994026263A2 Use of a transition metal complex for the treatment of septic shock |
11/24/1994 | WO1994026249A1 Compositions and methods for reparation and prevention of fibrotic lesions |
11/24/1994 | WO1994016709A3 Therapeutic uses and delivery systems of dehydroepiandrosterone |
11/24/1994 | CA2163095A1 Treatment process with biologically active tropane derivatives |
11/24/1994 | CA2162990A1 Inhibition of tumor necrosis factor and nitric oxide production by retinoic acid |
11/24/1994 | CA2162023A1 [1,2,4]triazolo[4,3-a]quinoxaline compounds, their preparation and use |
11/24/1994 | CA2161702A1 Pyrimidine derivatives |
11/24/1994 | CA2161648A1 Compositions and methods for reparation and prevention of fibrotic lesions |
11/24/1994 | CA2161021A1 Thioindole pyperidinyl derivatives used as antalgics |
11/24/1994 | CA2160776A1 Transdermal therapeutic systems for the administration of serotonin agonists |
11/24/1994 | CA2140260A1 4-(4-fluorophenylmethyl)-piperidines having sigma and d2-receptor affinity |
11/23/1994 | EP0625153A1 Novel isoindolinone derivative, preparation thereof, and pharmaceutical compositions containing same. |
11/23/1994 | EP0625149A1 Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists |
11/23/1994 | EP0625145A1 3-phenylureido-azepin-2-ones and -benzazepin-2-ones useful as cholecystokinin antagonists |
11/23/1994 | EP0543892B1 N-(mercaptoalkyl)ureas and carbamates |
11/23/1994 | EP0531461B1 Biologically active peptides containing d-2-alkyltryptophan |
11/23/1994 | CN1095380A Novel triazoloquinazolines, their preparation and use |
11/22/1994 | US5367081 Vasodilator, antiallergen |
11/22/1994 | US5366981 N-acyl-substituted azacyclic compounds, processes for their preparaion, and their use as pharmaceuticals |
11/22/1994 | US5366979 Orally active nonaddicting analgesics |
11/22/1994 | US5366973 Mercaptoacetylamido pyridazo [1,2]pyridazine, pyrazolo[1,2]pyridazine pyrazolo[1,2]pyridazine, pyridazol[1,2-a][1,2]diazepine and pyrazolol[1,2-a][1,2]diazepine |
11/22/1994 | CA1333176C Thiophene 2-carboxamide derivatives and their pharmaceutical use |
11/22/1994 | CA1333154C Memory enhancing-r-n-(1-azabicyclo[2.2.2]oct-3-yl) benzamides and thiobenzamides |
11/17/1994 | EP0624585A1 Process for the preparation of 2-(4-(4-(4-chloro-1-pyrazolyl)butyl)1-piperazinyl)pyrimidine |
11/17/1994 | EP0624584A1 Piperazine derivatives useful as calmodolin inhibitors |
11/17/1994 | EP0624569A1 NMDA antagonists |
11/17/1994 | EP0624371A1 Microcapsules for controlled release of acetylsalicylic acid |
11/17/1994 | EP0624366A1 Controlled release formulation containing tramadol |